Twinbeech Capital LP Jazz Pharmaceuticals PLC Transaction History

Twinbeech Capital LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$114.26 - $136.0 $7.74 Million - $9.21 Million	67,718 New	67,718 $8.33 Million
Q1 2023 May 15, 2023	BUY	$133.98 - $160.47 $2.18 Million - $2.61 Million	16,282 New	16,282 $2.38 Million
Q2 2022 Aug 15, 2022	BUY	$141.59 - $168.66 $1.1 Million - $1.31 Million	7,787 New	7,787 $1.22 Million
Q1 2022 May 16, 2022	SELL	$129.64 - $160.7 $2.02 Million - $2.5 Million	-15,549 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$119.87 - $145.67 $1.86 Million - $2.27 Million	15,549 New	15,549 $1.98 Million
Q2 2021 Aug 16, 2021	SELL	$160.2 - $186.42 $1.15 Million - $1.33 Million	-7,150 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$150.19 - $173.5 $1.07 Million - $1.24 Million	7,150 New	7,150 $1.18 Million

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.